» Articles » PMID: 26629491

Lectin Staining and Western Blot Data Showing Differential Sialylation of Nutrient-deprived Cancer Cells to Sialic Acid Supplementation

Overview
Journal Data Brief
Date 2015 Dec 3
PMID 26629491
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

This report provides data that are specifically related to the differential sialylation of nutrient deprived breast cancer cells to sialic acid supplementation in support of the research article entitled, "Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation" [1]. Particularly, breast cancer cells, when supplemented with sialic acid under nutrient deprivation, display sialylated glycans at the cell surface, but non-malignant mammary cells show sialylated glycans intracellularly. The impact of sialic acid supplementation under nutrient deprivation was demonstrated by measuring levels of expression and sialylation of two markers, EGFR1 and MUC1. This Data in Brief article complements the main manuscript by providing detailed instructions and representative results for cell-level imaging and Western blot analyses of changes in sialylation during nutrient deprivation and sialic acid supplementation. These methods can be readily generalized for the study of many types of glycosylation and various glycoprotein markers through the appropriate selection of fluorescently-labeled lectins.

Citing Articles

Simplifying the detection and monitoring of protein glycosylation during in vitro glycoengineering.

Saunders M, Woods R, Yang L Sci Rep. 2023; 13(1):567.

PMID: 36631484 PMC: 9834283. DOI: 10.1038/s41598-023-27634-z.


Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression.

Saeui C, Cho K, Dharmarha V, Nairn A, Galizzi M, Shah S Front Chem. 2020; 8:13.

PMID: 32117864 PMC: 7013041. DOI: 10.3389/fchem.2020.00013.


Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.

Saeui C, Nairn A, Galizzi M, Douville C, Gowda P, Park M PLoS One. 2018; 13(5):e0195812.

PMID: 29847599 PMC: 5976204. DOI: 10.1371/journal.pone.0195812.


Cancer cell death induced by nanomagnetolectin.

AlSadek D, Badr H, Al-Shafie T, El-Bahr S, El-Houseini M, Djansugurova L Eur J Cell Biol. 2017; 96(6):600-611.

PMID: 28521959 PMC: 5610079. DOI: 10.1016/j.ejcb.2017.04.005.


Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Badr H, AlSadek D, El-Houseini M, Saeui C, Mathew M, Yarema K Biomaterials. 2016; 116:158-173.

PMID: 27926828 PMC: 5193387. DOI: 10.1016/j.biomaterials.2016.11.044.

References
1.
Geisler C, Jarvis D . Effective glycoanalysis with Maackia amurensis lectins requires a clear understanding of their binding specificities. Glycobiology. 2011; 21(8):988-93. PMC: 3130539. DOI: 10.1093/glycob/cwr080. View

2.
Badr H, ElSayed A, Ahmed H, Dwek M, Li C, Djansugurova L . Preferential lectin binding of cancer cells upon sialic acid treatment under nutrient deprivation. Appl Biochem Biotechnol. 2013; 171(4):963-74. PMC: 3813469. DOI: 10.1007/s12010-013-0409-6. View

3.
Badr H, AlSadek D, Mathew M, Li C, Djansugurova L, Yarema K . Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation. Biomaterials. 2015; 70:23-36. PMC: 4658327. DOI: 10.1016/j.biomaterials.2015.08.020. View

4.
Bonay P, Munro S, Fresno M, Alarcon B . Intra-Golgi transport inhibition by megalomicin. J Biol Chem. 1996; 271(7):3719-26. DOI: 10.1074/jbc.271.7.3719. View